Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 15, 2007 19:31 ET | Source: Encysive Pharmaceuticals Inc.

FDA Issues Third Approvable Letter for Thelin (Sitaxsentan Sodium)

HOUSTON, June 15, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that the Company has received its third approvable letter from the U.S. Food and Drug...
May 30, 2007 17:46 ET | Source: Encysive Pharmaceuticals Inc.

Canadian Health Authority Approves THELIN (Sitaxsentan Sodium) for Pulmonary Arterial Hypertension

HOUSTON, May 30, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that Health Canada's Therapeutic Products Directorate has approved THELIN(tm) (sitaxsentan sodium) 100...
May 07, 2007 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Reports First Quarter 2007 Financial Results

HOUSTON, May 7, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the first quarter ended March 31, 2007. "In the quarter, we made significant...
May 01, 2007 02:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Previews European Union Activities for 2007

HOUSTON, May 1, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) and Encysive (UK) Limited, the Company's European operations, today announced plans to participate in three...
April 18, 2007 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Conference Call to Discuss First Quarter 2007 Results

HOUSTON, April 18, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) will hold an investor conference call on Monday, May 7, 2007 at 8:00 a.m. ET to discuss its first quarter 2007...
April 16, 2007 02:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Launch of THELIN (Sitaxentan Sodium) in the Netherlands

HOUSTON, April 16, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets in the Netherlands...
April 02, 2007 03:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Launch of Thelin (Sitaxentan Sodium) in Republic of Ireland

HOUSTON, April 2, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced the commercial availability of THELIN(r)(a)(sitaxentan sodium(b)) 100 mg tablets in the Republic of...
March 21, 2007 08:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Patient Enrollment Initiated for TBC3711 Phase II Study

HOUSTON, March 21, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that the first patient has been enrolled into its Phase II dose-ranging study of oral TBC3711,...
March 09, 2007 06:45 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Reports Fourth Quarter and Year End 2006 Financial Results

HOUSTON, March 9, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the fourth quarter and year ended December 31, 2006, and also provided financial...
March 07, 2007 05:00 ET | Source: Encysive Pharmaceuticals Inc.

THELIN (sitaxentan sodium) Receives Australian Marketing Approval

HOUSTON, March 7, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that the Australian Therapeutic Goods Administration (TGA) has granted marketing approval for...